Severe cutaneous drug reactions in children

被引:0
|
作者
Mockenhaupt, Maja [1 ,2 ]
机构
[1] Univ Klin Dermatol & Venerol, Dokumentat Zentrum Schwerer Hautreakt dZh, Freiburg, Germany
[2] Univ Klin Dermatol & Venerol, Dokumentat Zentrum Schwerer Hautreakt dZh, Hauptstr 7, D-79104 Freiburg, Germany
关键词
Epidermal necrolysis; Drug reaction with eosinophilia and systemic symptoms; Anticonvulsants; Sulfonamides; Sulfasalazine; STEVENS-JOHNSON-SYNDROME; TOXIC EPIDERMAL NECROLYSIS; SYSTEMIC SYMPTOMS; MULTIFORME MAJUS; DRESS; EPIDEMIOLOGY; SCORTEN;
D O I
10.1007/s00112-023-01753-3
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
Severe cutaneous drug reactions also occur in children and range from reactions with blister forming of skin and mucosa to extensive exanthems with altered differential blood count and involvement of internal organs. The first group includes Stevens-Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN), which are considered as one disease entity with different degrees of severity and are also referred to as "epidermal" or "epithelial necrolysis" (EN). The group of drug reactions with primarily systemic alterations is represented by a condition known as drug reaction with eosinophilia and systemic symptoms (DRESS). Although EN is generally considered as a drug reaction, a causative agent can only be identified in about 50% of all pediatric cases. Once a clear diagnosis is established, specific treatment measures should be carried out, whereby discontinuation of the causative agent plays a decisive role in drug-induced cases. In order to be able to identify and discontinue the drug responsible, a detailed medication history must be obtained. Certain antiepileptic drugs, sulfonamides and sulfasalazine are among the most frequent triggers of EN and DRESS in children. Supportive therapy including appropriate topical treatment, pain management and ophthalmological consultations are of utmost importance in EN but a short-term immunomodulating treatment with cyclosporine A has been shown to be helpful. In contrast, in DRESS middle to long-term systemic treatment with glucocorticosteroids is recommended.
引用
收藏
页码:439 / 451
页数:13
相关论文
共 50 条
  • [1] Severe cutaneous Drug Reactions in Children
    Mockenhaupt, M.
    HAUTARZT, 2017, 68 (10): : 803 - 814
  • [2] Severe cutaneous drug reactions
    Wilmer, A
    Wollina, U
    MEDIZINISCHE WELT, 1997, 48 (05): : 152 - 157
  • [3] Cutaneous Drug Reactions in Children
    Newell, Brandon D.
    Horii, Kimberly A.
    PEDIATRIC ANNALS, 2010, 39 (10): : 618 - 625
  • [4] Severe cutaneous adverse drug reactions
    Chung, Wen-Hung
    Wang, Chuang-Wei
    Dao, Ro-Lan
    JOURNAL OF DERMATOLOGY, 2016, 43 (07): : 758 - 766
  • [5] Severe Cutaneous Adverse Drug Reactions
    Schroeder, J.
    DRUG SAFETY, 2013, 36 (09) : 942 - 942
  • [6] Recognition and management of severe cutaneous drug reactions
    Knowles, Sandra R.
    Shear, Neil H.
    DERMATOLOGIC CLINICS, 2007, 25 (02) : 245 - +
  • [7] Cutaneous Drug Reactions in Children: An Update
    Heelan, Kara
    Shear, Neil H.
    PEDIATRIC DRUGS, 2013, 15 (06) : 493 - 503
  • [8] Treatment of severe cutaneous adverse drug reactions
    Ingen-Housz-Oro, S.
    Duong, T-A
    de Prost, N.
    Colin, A.
    Fardet, L.
    Lebrun-Vignes, B.
    Barbaud, A.
    Chosidow, O.
    Wolkenstein, P.
    ANNALES DE DERMATOLOGIE ET DE VENEREOLOGIE, 2018, 145 (6-7): : 454 - 464
  • [9] Severe cutaneous drug reactions to celecoxib (Celebrex®).
    Marqués, S
    Milpied, B
    Foulc, P
    Barbarot, S
    Cassagnau, E
    Stadler, JF
    ANNALES DE DERMATOLOGIE ET DE VENEREOLOGIE, 2003, 130 (11): : 1051 - 1055
  • [10] Recognising severe cutaneous adverse drug reactions
    Chee, Paul
    MEDICAL JOURNAL OF AUSTRALIA, 2017, 207 (08) : 325 - +